Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diamandis

Showing results (671-680 of 924) with videos related to

Pageof 93
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicityEva Christensen, Melania Pintilie, Kenneth R Evans, et al.
British Journal of Cancer|March 10, 2001
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerH Kim, A Scorilas, D Katsaros, et al.
Radiology and Oncology|December 3, 2013
Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesManfred Schmitt, Viktor Magdolen, Feng Yang, et al.
Biochimica Et Biophysica Acta|August 2, 2003
The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluidsGeorge M Yousef, Carl Kapadia, Mary-Ellen Polymeris, et al.
Journal of Proteomics|April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachIlijana Begcevic, Davor Brinc, Marshall Brown, et al.
Clinical Biochemistry|June 22, 2018
Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancerPanagiota S Filippou, Annie H Ren, Sudarshan Bala, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Thrombosis and Haemostasis|April 8, 2009
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancerMaroulio Talieri, Konstantina Mathioudaki, Panagiotis Prezas, et al.
Biological Chemistry|August 26, 2014
Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progressionGeorge S Karagiannis, Natasha Musrap, Punit Saraon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2008
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapseAnja Rabien, Florian Fritzsche, Monika Jung, et al.
Pageof 93

Showing results (671-680 of 924) with videos related to

Sort By:
Pageof 93
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicityEva Christensen, Melania Pintilie, Kenneth R Evans, et al.
British Journal of Cancer|March 10, 2001
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerH Kim, A Scorilas, D Katsaros, et al.
Radiology and Oncology|December 3, 2013
Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesManfred Schmitt, Viktor Magdolen, Feng Yang, et al.
Biochimica Et Biophysica Acta|August 2, 2003
The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluidsGeorge M Yousef, Carl Kapadia, Mary-Ellen Polymeris, et al.
Journal of Proteomics|April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachIlijana Begcevic, Davor Brinc, Marshall Brown, et al.
Clinical Biochemistry|June 22, 2018
Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancerPanagiota S Filippou, Annie H Ren, Sudarshan Bala, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Thrombosis and Haemostasis|April 8, 2009
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancerMaroulio Talieri, Konstantina Mathioudaki, Panagiotis Prezas, et al.
Biological Chemistry|August 26, 2014
Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progressionGeorge S Karagiannis, Natasha Musrap, Punit Saraon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 24, 2008
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapseAnja Rabien, Florian Fritzsche, Monika Jung, et al.
Pageof 93